Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mesoblast Ltd (MSB.AX)

Mesoblast Ltd (MSB.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mesoblast Ltd Level 38, 55 Collins Street Melbourne VIC 3000 AUS

https://www.mesoblast.com P: +61 396396036 F: +61 396396030

Description:

Mesoblast Ltd is a clinical-stage biotechnology company. It develops and commercializes innovative allogeneic cellular medicines to treat complex diseases resistant to the conventional standard of care. Its portfolio of Phase 3 product candidates comprises remestemcel-L for the treatment of steroid-refractory acute graft versus host disease (SR-aGVHD), and for moderate to severe acute respiratory distress syndrome (ARDS) and others.

Key Statistics

Overview:

Market Capitalization, $K 1,060,862
Shares Outstanding, K 1,014,799
Annual Sales, $ 7,501 K
Annual Net Income, $ -81,889 K
Last Quarter Sales, $ 2,139 K
Last Quarter Net Income, $ -21,919 K
% of Institutional Shareholders 9.46%

Growth:

1-Year Return 6.29%
3-Year Return -52.43%
5-Year Return -40.38%
5-Year Revenue Growth -15.07%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.09
EPS Growth vs. Prev Year -4.00%
Dividend Payout Ratio 0.00%

MSB.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -14.49%
Return-on-Assets % -10.92%
Profit Margin % -1,091.71%
Debt/Equity 0.21
Price/Sales 67.85
Price/Book 1.35
Book Value/Share 0.69
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar